Navigation Links
Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009
Date:4/15/2009

cer cells, enhancing the effectiveness of current cancer therapies.
  • Neuroscience
    • Abbott is conducting innovative research in neuroscience, where we have developed compounds that target receptors in the brain that help regulate mood, memory and other neurological functions to address conditions such as attention deficit hyperactivity disorder, Alzheimer's disease and schizophrenia.
  • Immunology
    • Abbott's scientific experience with the anti-TNF biologic HUMIRA serves as a strong foundation for our continuing research in immunology. HUMIRA has several indications in Phase III including ulcerative colitis and pediatric Crohn's disease. Also in Phase III is ABT-874, Abbott's anti-IL 12/23 biologic for psoriasis and Crohn's disease. We are also working to advance development of our early discovery programs, including oral DMARD therapies, as well as other potential biologic targets.
    • Additionally, our proprietary DVD-ig technology represents an innovative approach that can target multiple disease-causing antigens with a single biologic agent.
  • Hepatitis C
    • Abbott's antiviral program is focused on the treatment of hepatitis C, a disease that affects more than 180 million people worldwide. Abbott's broad-based hepatitis C program includes our partnership with Enanta Pharmaceuticals to develop protease inhibitors as well as our internal polymerase inhibitor program. Abbott has three HCV compounds in clinical development.
  • Vascular Devices
    • XIENCE PRIME - Abbott's next-generation DES that capitalizes on the proven attributes of XIENCE V while improving deliverability, especially in longer lengths and complex anatomy. We expect to launch XIENCE PRIME in Europe by year-end 2009.'/>"/>

    SOURCE Abbott
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine news :

    1. Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
    2. Abbott Hosts Conference Call for First-Quarter Earnings
    3. Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
    4. Abbott to Present at Cowen Annual Health Care Conference
    5. Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of Its AMO Subsidiary
    6. Abbott Completes Acquisition of Advanced Medical Optics
    7. Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore
    8. Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
    9. Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
    10. Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument
    11. Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/25/2014)... 25, 2014 Eye & Vision has ... their office location by expanding a new specialized ocular ... comprehensive visual electro-physiology clinic. , By acquiring specialized Visual ... experience in vision problems, patients with vision loss in ... advantage of the implementation of this specialized vision testing ...
    (Date:7/25/2014)... The European liquid chromatography reagents report defines and ... forecast of revenue. The liquid chromatography reagents market in ... and is estimated to grow to around $1581.8 million ... 2013 to 2018. , Browse through the TOC of ... idea of the in-depth analysis provided. This also provides ...
    (Date:7/25/2014)... FRIDAY, July 25, 2014 (HealthDay News) -- Twins, genes ... their environment, according to a new study. ... vocabulary, putting words together and grammar, were largely inherited. ... that the "twinning effect" (a lower level of language ... identical twins than non-identical twins. "This finding disputes ...
    (Date:7/25/2014)... -- A protein that controls when genes are switched ... areas of the brain to regulate metabolism, UT Southwestern ... lead to new therapies to treat obesity and diabetes, ... protein 1 (Xbp1s) appears to influence the body,s ... are hormones central to the body,s regulation of food ...
    (Date:7/25/2014)... 2014 The American Brain Tumor Association ... Development Trainer of Distinguished Events, and Corporate and Special ... Cancer Society, will be joining the ABTA in the ... will oversee the roll out of a nationwide brain ... The recently launched volunteer network will provide the Chicago-based ...
    Breaking Medicine News(10 mins):Health News:Eye & Vision, a Leading Eye Doctor Group in Richardson, Celebrate Milestone and Expand Scope of Specialized Eye Care 2Health News:Eye & Vision, a Leading Eye Doctor Group in Richardson, Celebrate Milestone and Expand Scope of Specialized Eye Care 3Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 2Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 3Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Genes May Be Key to Language Delay in Kids 2Health News:Manipulating key protein in the brain holds potential against obesity and diabetes 2Health News:American Brain Tumor Association Recruits Director to Lead New Volunteer Network 2
    ... Pradesh government has decided to prepone the Japanese Encephalitis immunisation ... the centre// as they feel that it might not be ... ,It has been decided that the immunisation campaign ... undertaken on May 15, 2006 itself. 5.2 million doses of ...
    ... to aid the formation of insulin crystals in the ... of Houston professor and his student, which holds promise ... ,Peter Vekilov, associate professor of chemical engineering, ... engineering, both in UH's Cullen College of Engineering, have ...
    ... the Arab world is awakening to the growing menace of ... especially true in Dubai//. ,In order to effectively deal ... are addressing this problem openly and stressing on the adverse ... that more and more officials and religious leaders were stressing ...
    ... from arthritis face increased risk of fractures in later ... M. Burnham of The Children's Hospital of Philadelphia and ... in Britain who had first experienced arthritis between ages ... patients to a larger control group of 207,000 patients ...
    ... recent study, women who use the contraceptive pill, Dianette, ... of developing depression//. ,Adverse Psychiatric Reactions Information Link, ... effective contraceptive licensed as a hormone treatment for acne, ... ,The women said they experienced serious depression while ...
    ... insurance plans show wide variations among different states with ... ,-Employees in the smallest firms (1-9 workers) ... than those in the largest firms (1,000+ workers), when ... a health plan--is taken into account, a new Commonwealth ...
    Cached Medicine News:Health News:Uttar Pradesh To Prepone The Japanese Encephalitis Immunisation Drive 2Health News:Uttar Pradesh To Prepone The Japanese Encephalitis Immunisation Drive 3Health News:Insulin Crystals Holds Promise In Diabetes research 2Health News:Health Insurance Plans Varies among States 2Health News:Health Insurance Plans Varies among States 3
    (Date:7/25/2014)... Leading events organizer UBM Live announces that CPhI ... São Paulo, Brazil from 5 th ... co-locate with Food Ingredients South America (FiSA), creating ... pharmaceutical industry.      (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a) Three ... exploring the South America market as ...
    (Date:7/24/2014)... 2014   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... date for Zalviso remains July 27, 2014.  ... stating the Food and Drug Administration (FDA) had approved ... no notification to the company from the FDA regarding ...
    (Date:7/24/2014)... MARSEILLE , Frankreich, July ... , Weltweite Exklusivlizenz der Universität ... Entwicklung von Tests auf SF3B1-Mutationen, einschließlich von ... Neuer Test weist Mutationen des SF3B1-Gens nach, ... einen günstigen Krankheitsverlauf vermuten lassen  ...
    Breaking Medicine Technology:CPhI South America 2014 Launches with Generics Showing Huge Growth 2CPhI South America 2014 Launches with Generics Showing Huge Growth 3CPhI South America 2014 Launches with Generics Showing Huge Growth 4AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
    ... Portable - Battery Powered (6 size AA ... conversion (g, ct, oz, ozt, GN, dwt, ... Counting and Percent Measure functions, Auto Print. ... Optional AC adapter may be ordered for ...
    ... speed, stability and durability. Back-lighted Display. ... multiple units of measure, piece counting ... and GLP/GMP/ISO output including date and ... calibration with external weights only (selectable ...
    60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure....
    60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure....
    Medicine Products: